[{"address1": "Grafenauweg 8", "city": "Zug", "zip": "6300", "country": "Switzerland", "phone": "31 712036410", "website": "https://pharvaris.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist for the treatment of attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), as well as in Phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.", "fullTimeEmployees": 118, "companyOfficers": [{"maxAge": 1, "name": "Mr. Berndt Axel Edvard Modig CPA, M.B.A.", "age": 65, "title": "Co-Founder, CEO & Executive Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 676242, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David W. Nassif J.D.", "age": 70, "title": "CFO, Chief Legal Officer & Corporate Secretary", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anna  Nijdam M.Sc., R.A.", "age": 43, "title": "Head of Strategic Finance & Principal Accounting Officer", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stefan  Abele Ph.D.", "age": 54, "title": "Chief Technology Operations Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Annick  Deschoolmeester", "age": 51, "title": "Chief Human Resources Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peng  Lu M.D., Ph.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anne A. Lesage Ph.D.", "age": 63, "title": "Chief Early Development Officer", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Wim  Souverijns Ph.D.", "age": 53, "title": "Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Maryann  Cimino", "title": "Director of Corporate Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 27.69, "open": 27.6, "dayLow": 25.86, "dayHigh": 27.915, "regularMarketPreviousClose": 27.69, "regularMarketOpen": 27.6, "regularMarketDayLow": 25.86, "regularMarketDayHigh": 27.915, "payoutRatio": 0.0, "beta": -2.8, "forwardPE": -8.662295, "volume": 450316, "regularMarketVolume": 450316, "averageVolume": 320598, "averageVolume10days": 733680, "averageDailyVolume10Day": 733680, "bid": 20.99, "ask": 28.0, "bidSize": 2, "askSize": 1, "marketCap": 1716228864, "fiftyTwoWeekLow": 11.51, "fiftyTwoWeekHigh": 29.797, "allTimeHigh": 42.86, "allTimeLow": 1.77, "fiftyDayAverage": 23.7396, "twoHundredDayAverage": 19.78135, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1387521792, "profitMargins": 0.0, "floatShares": 33470359, "sharesOutstanding": 64959454, "sharesShort": 444790, "sharesShortPriorMonth": 544623, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0068, "heldPercentInsiders": 0.05316, "heldPercentInstitutions": 0.96097, "shortRatio": 1.83, "shortPercentOfFloat": 0.0082, "impliedSharesOutstanding": 64959454, "bookValue": 4.807, "priceToBook": 5.4961514, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -163719488, "trailingEps": -3.38, "forwardEps": -3.05, "enterpriseToEbitda": -8.296, "52WeekChange": 0.425027, "SandP52WeekChange": 0.13506866, "quoteType": "EQUITY", "currentPrice": 26.42, "targetHighPrice": 76.87435, "targetLowPrice": 29.95109, "targetMeanPrice": 45.925655, "targetMedianPrice": 40.932804, "recommendationMean": 1.36364, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 329285632, "totalCashPerShare": 5.069, "ebitda": -167259872, "totalDebt": 578657, "quickRatio": 12.673, "currentRatio": 12.863, "debtToEquity": 0.185, "returnOnAssets": -0.32074, "returnOnEquity": -0.53764, "freeCashflow": -76153248, "operatingCashflow": -134074560, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "EUR", "symbol": "PHVS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Pharvaris N.V.", "longName": "Pharvaris N.V.", "exchange": "NMS", "messageBoardId": "finmb_402951024", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1764978637, "regularMarketTime": 1764968401, "regularMarketChangePercent": -4.58649, "regularMarketPrice": 26.42, "marketState": "CLOSED", "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -3.38, "epsForward": -3.05, "epsCurrentYear": -2.7542, "priceEpsCurrentYear": -9.592622, "fiftyDayAverageChange": 2.6804008, "fiftyDayAverageChangePercent": 0.11290843, "twoHundredDayAverageChange": 6.638651, "twoHundredDayAverageChangePercent": 0.3356015, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "prevName": "Pharvaris B.V.", "nameChangeDate": "2025-12-05", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "postMarketChangePercent": -0.45420453, "postMarketPrice": 26.3, "postMarketChange": -0.12000084, "regularMarketChange": -1.27, "regularMarketDayRange": "25.86 - 27.915", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 320598, "fiftyTwoWeekLowChange": 14.91, "fiftyTwoWeekLowChangePercent": 1.2953953, "fiftyTwoWeekRange": "11.51 - 29.797", "fiftyTwoWeekHighChange": -3.3770008, "fiftyTwoWeekHighChangePercent": -0.11333358, "fiftyTwoWeekChangePercent": 42.5027, "earningsTimestamp": 1762954200, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "displayName": "Pharvaris", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]